Details for 2017728095
Up to date per 02.04.2026
Actions
Details for 2017728095
Granted/Registered
European Patent
10.04.2019 A
07.10.2020 B1
27.05.2016
WO
PCT/EP2016/062085
A61K 38/48 20060101AFI20200402BHEP
Owner
Ipsen Biopharm LimitedUnit 9, Ash Road Wrexham Industrial Estate Wrexham LL13 9UFGB
Galderma Holding SAZählerweg 106300 ZugCH
Representative
No representatives present
Inventor
JARSTAD, AndersBernadottevägen 1 L 756 48 UppsalaSE
FRIIS, AnnaDanmarks-Berga 57 755 98 UppsalaSE
STAHL, UlfSolrosgatan 9 75324 UppsalaSE
GURELL, AnnKarlbergsvägen 71 B, Igh 1201 113 35 StockholmSE
AGREN, BarbroYtterocke 212 830 02 MattmarSE
EDSTROM, EmiliaOslogatan 61 75264 UppsalaSE
PICKETT, AndrewHålsomsvägen 35 757 57 UppsalaSE
Information about Fees